ursolic acid has been researched along with amphotericin b in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Bourdy, G; Eparvier, V; Herbette, G; Odonne, G; Rojas, R; Sauvain, M; Stien, D | 1 |
| Campos, BL; Corbett, CE; Grecco, Sdos S; Lago, JH; Laurenti, MD; Passero, LF; Yamamoto, ES | 1 |
| Ferreira, AF; Fragoso, TN; Jesus, JA; Lago, JH; Laurenti, MD; Passero, LF; Santos-Gomes, G; Silva, MS; Yamamoto, ES | 1 |
| Croft, SL; Loiseau, PM; Pomel, S | 1 |
1 review(s) available for ursolic acid and amphotericin b
| Article | Year |
|---|---|
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid | 2020 |
5 other study(ies) available for ursolic acid and amphotericin b
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru). Part III.
Topics: Amphotericin B; Asteraceae; Chemical Fractionation; Dose-Response Relationship, Drug; Humans; Indians, South American; Inhibitory Concentration 50; Lactones; Leishmania; Medicine, Traditional; Peru; Plant Components, Aerial; Plant Extracts; Plants, Medicinal; Sesquiterpenes; Triterpenes; Trypanocidal Agents; Ursolic Acid | 2011 |
Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.
Topics: Amphotericin B; Animals; Baccharis; Immunity, Cellular; Interferon-gamma; Interleukin-12; Leishmania; Leishmaniasis, Cutaneous; Male; Mice; Mice, Inbred BALB C; Oleanolic Acid; Parasite Load; Plant Extracts; Plant Leaves; Th1 Cells; Triterpenes; Ursolic Acid | 2014 |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Baccharis; Drug Discovery; Female; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-4; Leishmaniasis, Visceral; Leukocytes, Mononuclear; Liver; Mesocricetus; Spleen; Triterpenes; Ursolic Acid | 2017 |